HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cystoid macular edema following immune recovery and treatment with cidofovir for cytomegalovirus retinitis.

AbstractBACKGROUND:
Cytomegalovirus (CMV) retinitis is the most common opportunistic ocular infection in AIDS patients. Cidofovir has proved to be highly effective in treatment of CMV retinitis. Iritis and bulbar hypotony are known as the major complications after intravenous and intravitreal use of this antiviral drug. Cystoid macular edema (CME) after intravenous application of cidofovir has not been reported.
METHODS:
We analyzed retrospectively the incidence of CME after intravitreal or intravenous application of cidofovir and its correlation with CD4 cell counts of the patients.
RESULTS:
Two (22.2%) of 9 eyes in the intravenous and 3 (18.8%) of 16 eyes in the intravitreal injection group developed CME. It occurred between 3 and 48 weeks after cidofovir administration. In all eyes CMV retinitis was inactive. All patients received highly active antiretroviral treatment (HAART). CME was correlated with a rapid and sustained improvement in CD4 cell counts.
CONCLUSION:
We interpret the occurrence of CME as an immune recovery phenomenon for the following reasons. All CMEs were seen in eyes with inactive CMV retinitis and the unaffected contralateral side never developed CME. The time range of appearance between 3 and 48 weeks after cidofovir administration makes direct toxicity of cidofovir unlikely. All patients had a sustained improvement of CD4 cell counts due to HAART. No CME was reported during the use of cidofovir before the HAART era.
AuthorsA J Kersten, C Althaus, J Best, R Sundmacher
JournalGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (Graefes Arch Clin Exp Ophthalmol) Vol. 237 Issue 11 Pg. 893-6 (Nov 1999) ISSN: 0721-832X [Print] Germany
PMID10541898 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antiviral Agents
  • Organophosphonates
  • Organophosphorus Compounds
  • Cytosine
  • Cidofovir
Topics
  • AIDS-Related Opportunistic Infections (drug therapy, immunology)
  • Antiviral Agents (administration & dosage, adverse effects)
  • CD4 Lymphocyte Count
  • Cidofovir
  • Cytomegalovirus Retinitis (drug therapy, immunology)
  • Cytosine (administration & dosage, adverse effects, analogs & derivatives)
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fundus Oculi
  • Humans
  • Injections, Intravenous
  • Macular Edema (chemically induced, diagnosis, epidemiology)
  • Organophosphonates
  • Organophosphorus Compounds (administration & dosage, adverse effects)
  • Retrospective Studies
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: